DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sai Life Sciences Limited — Board Meeting Intimation

NSE 1 hr ago·1 Oct 2026, 5:38 am

SAI Life Sciences

Sai Life Sciences has announced that its board will meet on November 5, 2026, to review and approve the company's unaudited financial results for the third quarter of the fiscal year ending September 2026. This is a standard corporate procedure where the board reviews the company's performance before the results are officially released to the public and stock exchanges.

For investors, this meeting is a key milestone as it signals that the company is preparing to disclose its quarterly earnings. The release of these results will provide fresh data on the company's operational efficiency, revenue growth, and profitability, which are critical factors for evaluating the stock's current performance and future potential.

Investors should watch for the specific financial figures released during this period. Any significant deviation from market expectations or commentary from management regarding future outlooks can lead to volatility in the stock price. Keeping an eye on the official filing will help in understanding the company's health ahead of the broader market reaction.